Australia Wearables in Pharma & Biotech Market (2026-2031)
The Australia Wearables in Pharma & Biotech Market was valued at $55.4 Million in 2026 and projected to reach to $140.2 Million by 2031, representing a compound annual growth rate of CAGR 20.4%. Australia's wearables in pharma and biotech market is positioned for sustained growth through 2031, driven by increasing adoption of remote patient monitoring, digital therapeutics, and connected health devices.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia Wearables in Pharma & Biotech Market Trends and Insights
- This represents a compound annual growth rate of 20.4%, reflecting strong adoption of digital health technologies and remote patient monitoring solutions across Australia's healthcare ecosystem.
- Australia's advanced healthcare infrastructure and high digital literacy rates are driving demand for wearable devices that enable continuous health tracking, medication adherence monitoring, and real-time clinical data collection. The Australian market is characterized by increasing investment in digital therapeutics and personalized medicine initiatives.
- Australia's regulatory environment and healthcare reimbursement models are increasingly supportive of wearable technologies, encouraging both established pharmaceutical companies and biotech startups to integrate wearables into their product portfolios.
- Between 2026 and 2031, Australia is expected to see significant growth in remote patient monitoring, chronic disease management, and clinical trial applications of wearable devices. Australia's position within the Asia Pacific region positions it as a key market for wearable innovation and adoption.
- The convergence of aging demographics, rising healthcare costs, and technological advancement is accelerating wearable integration across Australia's pharmaceutical and biotech sectors, making it a critical growth market for industry stakeholders..
Key Market Statistics
- CAGR (2026-2031) CAGR 20.4%
- Market Size, 2026 ~USD 55.4 Million
- Forecast, 2031 ~USD 140.2 Million
- Country Australia
Australia Wearables in Pharma & Biotech Market Overview
Market Valuation Growth :
Australia's wearables in pharma and biotech market is valued at USD 55.4 million in 2026, with projections reaching USD 140.2 million by 2031, demonstrating strong market momentum and investment potential.
Accelerated CAGR Performance :
The Australian market is growing at 20.4% CAGR, outpacing the global average of 20.2%, indicating Australia's leadership in digital health adoption and wearable technology integration within the pharmaceutical sector.
Remote Patient Monitoring Adoption :
Strong uptake of remote patient monitoring solutions across Australia's healthcare ecosystem is driving wearable adoption, supported by advanced healthcare infrastructure and government digital health initiatives.
Digital Health Infrastructure :
Australia's mature healthcare system and investment in digital health technologies create a favorable environment for wearable devices in clinical trials, patient monitoring, and therapeutic applications.
Australia Wearables in Pharma & Biotech Market Dynamics
- The market benefits from Australia's advanced healthcare infrastructure, regulatory support for digital health innovations, and growing investment in precision medicine initiatives. Key growth drivers include rising chronic disease prevalence, aging population demographics, and healthcare provider demand for real-time patient data.
- Pharmaceutical companies and biotech firms are increasingly integrating wearable technologies into clinical trials and post-market surveillance programs, creating significant opportunities for market expansion and innovation across the Australian healthcare landscape..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- Australia's wearables in pharma & biotech market will grow from USD 55.4M (2026) to USD 140.2M (2031) at a 20.4% CAGR.
- Australia's advanced healthcare infrastructure and digital literacy are key drivers of wearable adoption in pharmaceutical and biotech applications.
- Remote patient monitoring and chronic disease management represent the fastest-growing segments in Australia's wearable market.
- Australia's supportive regulatory environment and reimbursement models are accelerating pharmaceutical and biotech company investment in wearable technologies.
Wearables in Pharma & Biotech Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 20.2% from 2026 to 2031 |
| Largest Segment | PHARMACEUTICAL & BIOTECH COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 3.97 (2026) |
| Revenue Forecast (Billions) | ~USD 9.97 (2031) |
| Segments Covered | Product, Therapeutic Area, Type, Application, End User |
Australia Wearables in Pharma & Biotech Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Continuous Glucose Monitors
- Fitness Bands
- Other Products
- Patches
- Smart Rings
- Smartwatches
- Wearable Injectors
By Therapeutic Area
- Cardiovascular
- Diabetes
- Lifestyle & Wellness Improvement
- Mental Health & Behavioral Health
- Musculoskeletal Disorders/Pain Management
- Neurology
- Oncology
- Other Diseases
- Respiratory Disorders
- Women’S Health & Reproductive Health
By Type
- Atherosclerotic Cardiovascular Diseases/Secondary Prevention
- Atrial Fibrillation/Stroke Prevention
- Brain Tumor
- Breast Cancer
- Colorectal Cancer
- Heart Failure
- Hematologic Malignancies
- Hypertension
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Other Hematologic Malignancies
- Other Solid Tumors
- Phase Ii
- Phase Iii
- Phase Iv
- Prostate Cancer
- Pulmonary Hypertension
- Solid Tumors
- Structural Heart Diseases/Interventional Cardiology
By Application
- Chronic Disease Monitoring
- Clinical Trials
- Drug Discovery
- Medication Adherence & Behavioral Support
- Personalized & Preventive Digital Therapeutics
By End User
- Contract Research Organizations
- Healthcare Providers & Clinicians
- Other End Users
- Pharmaceutical & Biotech Companies
AUSTRALIA: WEARABLES IN PHARMA & BIOTECH MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CONTRACT RESEARCH ORGANIZATIONS | 12.8 | 15.3 | 18.4 | 22.2 | 26.9 | 32.7 | 39.8 | 48.7 | 21.5 |
| HEALTHCARE PROVIDERS & CLINICIANS | 3.9 | 4.5 | 5.3 | 6.3 | 7.5 | 9 | 10.7 | 12.9 | 19.3 |
| OTHER END USERS | 2.3 | 2.6 | 3.1 | 3.6 | 4.3 | 5 | 5.9 | 7 | 17.8 |
| PHARMACEUTICAL & BIOTECH COMPANIES | 20.4 | 24.1 | 28.6 | 34.1 | 40.9 | 49.2 | 59.3 | 71.7 | 20.2 |
| TOTAL | 39.4 | 46.6 | 55.4 | 66.3 | 79.6 | 95.8 | 115.8 | 140.2 | 20.4 |
Target Audience
- Pharmaceutical Companies : Australian and international pharma firms need market intelligence to integrate wearables into clinical trials, post-market surveillance, and patient engagement programs within Australia's regulated healthcare environment.
- Biotech Innovators : Biotech companies developing wearable-enabled therapeutics require Australia-specific data on market demand, regulatory pathways, and healthcare provider adoption to guide product commercialization strategies.
- Medical Device Manufacturers : Device makers targeting the Australian market need insights into wearable technology integration opportunities, competitive landscape, and healthcare system requirements for successful market penetration.
- Healthcare Investors & Venture Capital : Investment firms evaluating opportunities in Australia's digital health sector require market sizing, growth projections, and trend analysis to identify high-potential wearable technology investments.
- Healthcare Providers & Institutions : Australian hospitals, clinics, and healthcare networks need market data on wearable solutions to inform procurement decisions, digital health strategy development, and patient monitoring program implementation.
Key Companies in the Australia Wearables in Pharma & Biotech Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market-Specific Growth Intelligence : Gain detailed insights into Australia's 20.4% CAGR trajectory and USD 85 million market expansion opportunity from 2026-2031, enabling precise investment and expansion strategies tailored to the Australian market.
- Competitive Positioning Data : Understand Australia's outperformance versus global benchmarks (20.2% CAGR) to identify competitive advantages, market gaps, and opportunities for differentiation in the regional wearables ecosystem.
- Regulatory & Infrastructure Insights : Access Australia-specific analysis of healthcare infrastructure, regulatory frameworks, and digital health policies that influence wearable adoption, clinical integration, and market entry strategies.
- Segment & Application Breakdown : Obtain granular data on remote patient monitoring, clinical trial applications, and therapeutic wearables specific to Australia's pharmaceutical and biotech sectors for targeted product development.
- Strategic Decision Support : Leverage Australia-focused market forecasts and trend analysis to support partnership decisions, R&D investments, and go-to-market strategies within the high-growth Australian healthcare wearables market.
Frequently asked questions
What is the current market size of wearables in pharma & biotech in Australia?
Australia's wearables in pharma and biotech market is valued at USD 55.4 million in 2026, with verified data confirming this as the baseline for market analysis.
What is the projected market size for Australia's wearables in pharma & biotech by 2031?
Australia's wearables in pharma and biotech market is forecast to reach USD 140.2 million by 2031, representing significant growth over the five-year forecast period.
What is the CAGR for Australia's wearables in pharma & biotech market?
Australia's wearables in pharma and biotech market is expected to grow at a compound annual growth rate of 20.4% from 2026 to 2031.
What are the primary drivers of growth in Australia's wearables market?
Australia's growth is driven by advanced healthcare infrastructure, high digital literacy, supportive regulatory frameworks, and increasing adoption of remote patient monitoring and digital therapeutics.
Which applications are leading growth in Australia's wearables in pharma & biotech market?
Remote patient monitoring, chronic disease management, medication adherence tracking, and clinical trial applications are the primary growth segments in Australia's wearable market.
RESEARCH METHODOLOGY
This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.
Market Definition
The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.
Key Stakeholders
- Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
- Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
- Component, sensor, & semiconductor technology providers
- Pharmaceutical companies
- Biotechnology companies
- Contract research organizations (CROs)
- Clinical trial sponsors & site management organizations
- Healthcare providers (hospitals, clinics, remote patient monitoring programs)
- Patients & caregivers
- Payers & insurers
- Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
- Academic institutions & research organizations
- Data management, interoperability & cloud infrastructure providers
- Cybersecurity & data privacy solution providers
- System integrators & IT service providers
- Venture capital & private equity firms
- Investors & financial institutions
- Consulting, regulatory, & compliance service providers
Report Objectives
- To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market
Customization Options:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company.
Geographic Analysis
- Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries
Get the Full Wearables in Pharma & Biotech Market Report
Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.
- US Wearables in Pharma & Biotech Market
- Canada Wearables in Pharma & Biotech Market
- Germany Wearables in Pharma & Biotech Market
- France Wearables in Pharma & Biotech Market
- UK Wearables in Pharma & Biotech Market
- Italy Wearables in Pharma & Biotech Market
- Spain Wearables in Pharma & Biotech Market
- China Wearables in Pharma & Biotech Market
- Japan Wearables in Pharma & Biotech Market
- India Wearables in Pharma & Biotech Market
- South Korea Wearables in Pharma & Biotech Market
- Brazil Wearables in Pharma & Biotech Market
- Mexico Wearables in Pharma & Biotech Market
- Saudi Arabia Wearables in Pharma & Biotech Market
- UAE Wearables in Pharma & Biotech Market
- South Africa Wearables in Pharma & Biotech Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report